Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte's arginase activation

• Egile Nagusiak: Gamaleldin I. Harisa (Egilea), Sabry M. Attia (Egilea), Khairy M.A. Zoheir (Egilea), Fars K. Alanazi (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2017-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

This study aimed to evaluate the protective effect of chitosan (CS) against hypercholesterolemia (HC) induced arginase activation and disruption of nitric oxide (NO) biosynthesis using erythrocytes as cellular model. Human erythrocytes were isolated and classified into eight groups. Next, cells were...